2023 Form 5500 filing — Aurobindo Pharma U.S.A., Inc. 401(K) Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241010093038NAL0020758609001) for Aurobindo Pharma U.S.A., Inc. 401(K) Plan, reported by Aurobindo Pharma U.S.A., Inc. under EIN 20-0962874 and plan number 001. It reports 785 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
- EFAST2 acknowledgement
- 20241010093038NAL0020758609001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Aurobindo Pharma U.S.A., Inc.
- EIN
- 20-0962874
- Plan number
- 001
- Location
- East Windsor, NJ
- Participants
- 785
- Schedules available
- Schedule H, Schedule C
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $43,087,557
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $43,087,557
- Employer contributions
- $1,458,739
- Participant contributions
- $4,145,770
- Total income / additions
- $12,464,639
- Benefits paid
- $4,049,114
- Administrative expenses
- $124,156
- Total expenses
- $4,173,270
- Net increase / (decrease)
- $8,291,369
- Schedule source
- Schedule H
Reported service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. |
|---|---|---|---|
| Global Retirement Partners LLC | ADVISOR | $92,399 | not reported in the loaded dataset |
| Withumsmith+Brown | ACCOUNTANT/AUDITOR | $29,422 | not reported in the loaded dataset |
| Fidelity Investments Institutional | RECORDKEEPER | -$96 | $0 |